- Home
- CELC vs MHO Comparison
CELC vs MHO Comparison
Compare CELC & MHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CELC | MHO |
|---|---|---|
| Founded | 2011 | 1976 |
| Country | United States | United States |
| Employees | N/A | 1801 |
| Industry | Medical Specialities | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.3B |
| IPO Year | 2017 | 1995 |
Fundamental Metrics
Financial Performance| Metric | CELC | MHO |
|---|---|---|
| Price | $114.28 | $128.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 2 |
| Target Price | $106.63 | ★ $160.00 |
| AVG Volume (30 Days) | ★ 527.9K | 209.0K |
| Earning Date | 01-01-0001 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 14.74 |
| Revenue | N/A | ★ $4,417,781,000.00 |
| Revenue This Year | N/A | $0.66 |
| Revenue Next Year | N/A | $6.97 |
| P/E Ratio | ★ N/A | $8.70 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.58 | $100.22 |
| 52 Week High | $120.32 | $158.92 |
Technical Indicators
Market Signals| Indicator | CELC | MHO |
|---|---|---|
| Relative Strength Index (RSI) | 56.01 | 31.47 |
| Support Level | $97.75 | $124.48 |
| Resistance Level | $114.54 | $130.50 |
| Average True Range (ATR) | 5.14 | 4.39 |
| MACD | 0.36 | -1.84 |
| Stochastic Oscillator | 63.53 | 14.17 |
Price Performance
Historical ComparisonAbout CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About MHO M/I Homes Inc.
M/I Homes Inc is an American construction company that focuses on residential construction. It consists of two distinct operations: homebuilding and financial services. The homebuilding operations are spread into the Midwest, Mid-Atlantic, and Southern regions, and the financial services operations support homebuilding operations by providing mortgage loans and title services to the customers of homebuilding operations. Homebuilding operations comprises a predominant portion of the revenue. The company builds homes and communities that target entry-level, move-up, and luxury homebuyers.